Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript Inv. presentation
|
MYRIAD GENETICS INC (MYGN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/11/2023 |
8-K
| Quarterly results |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/27/2023 |
4
| Riggsbee Richard Bryan (CFO) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Paid exercise price by delivering 4,517 shares
@ $15.99, valued at
$72.2k
|
|
09/27/2023 |
4
| Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Paid exercise price by delivering 3,523 shares
@ $15.99, valued at
$56.3k
|
|
09/27/2023 |
4
| Lambert Nicole (COO) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Paid exercise price by delivering 4,402 shares
@ $15.99, valued at
$70.4k
|
|
09/27/2023 |
4
| Haas Kevin Richard (Chief Technology Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Paid exercise price by delivering 858 shares
@ $15.99, valued at
$13.7k
|
|
09/27/2023 |
4
| Muzzey Dale (Chief Scientific Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Paid exercise price by delivering 133 shares
@ $15.99, valued at
$2.1k
|
|
08/14/2023 |
4
| DIAZ PAUL J (President and CEO) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Paid exercise price by delivering 22,943 shares
@ $17.89, valued at
$410.5k
Paid exercise price by delivering 51,292 shares
@ $17.89, valued at
$917.6k
|
|
08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/03/2023 |
8-K
| Quarterly results |
07/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
06/02/2023 |
4
| BISARO PAUL (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 7,575 shares
@ $0 |
|
06/02/2023 |
4
| Kumar Rashmi (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 15,151 shares
@ $0 |
|
06/02/2023 |
4
| Skovronsky Daniel (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 15,151 shares
@ $0 |
|
06/02/2023 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 15,151 shares
@ $0 Sold 8,638 shares
@ $23.01, valued at
$198.8k
|
|
06/02/2023 |
4
| Reitan Colleen F (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 15,151 shares
@ $0 |
|
06/02/2023 |
4
| Newcomer Lee Nisley (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 15,151 shares
@ $0 |
|
06/02/2023 |
4
| Dreismann Heinrich (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 15,151 shares
@ $0 |
|
06/02/2023 |
4
| Phanstiel S. Louise (Director) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Granted 15,151 shares
@ $0 |
|
06/02/2023 |
8-K
| Appointed a new director |
06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/01/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
4
| Munk Natalie (Chief Accounting Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns:
| Paid exercise price by delivering 404 shares
@ $23.72, valued at
$9.6k
Paid exercise price by delivering 365 shares
@ $23.72, valued at
$8.7k
Paid exercise price by delivering 583 shares
@ $23.72, valued at
$13.8k
|
|
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|